Infectious Disease Alert – October 1, 2021

October 1, 2021

• Emerging Options for Malaria Prevention

  New data suggest that combining vaccination with chemoprophylaxis is better than either intervention alone, and a small pilot study suggests that a monoclonal antibody infusion is effective in preventing malaria infections.
  
  
  

  Read more

• Environmental Shedding of MRSA Is Far Greater than from Multidrug-Resistant Gram-Negative Bacilli

  An observational cohort study revealed shedding of methicillin-resistant Staphylococcus aureus by colonized patients outside hospital rooms or during outpatient clinic visits occurred more often than in those colonized by multidrug-resistant gram-negative bacilli.

  Read more

• Adjuvanted Zoster Vaccine: Persistent Protection

  The adjuvanted recombinant zoster vaccine efficacy is high and persistent, with apparent plateauing at > 84% four to six years after vaccination.

  Read more

• Well-Appearing Febrile Infants: New Guidelines for Evaluation and Management

  New guidelines provide specific recommendations for the use of diagnostic testing, antimicrobial treatment, and ongoing care based on age for children between 8 and 60 days of age.

  Read more

• SARS-CoV-2 Rapid Antigen Testing in a Nursing Home Outbreak

  Rapid antigen testing was accurate in detecting SARS-CoV-2 antigen when compared to polymerase chain reaction.

  Read more

• Infectious Disease Alert Updates

  Pyrethroids losing activity against mosquitoes; Resistance erodes standard treatment for pneumonia; and homelessness and COVID-19.

  Read more